Pharmabiz3h
Lupin receives US FDA approval for generic Atrovent nasal spray, 0.06%
Lupin receives US FDA approval for generic Atrovent nasal spray, 0.06%: Our Bureau,Mumbai Tuesday, January 28, 2025, 17:30 Hrs [IST] Global pharma major Lupin Limited (Lupin) anno ...
Pharmabiz3h
WCG introduces ClinSphere Total Enrollment: An all-new participant recruitment and retention SaaS solution for clinical trials
An all-new participant recruitment and retention SaaS solution for clinical trials: Princeton, New Jersey Tuesday, January 28, 2025, 18 ...
Pharmabiz4h
ManipalCigna Health Insurance drives awareness with free health checkup camps
ManipalCigna Health Insurance drives awareness with free health checkup camps: Our Bureau, Bengaluru Tuesday, January 28, 2025, 17:15 Hrs [IST] ManipalCigna Health Insurance in co ...
Pharmabiz4h
Lupin and Avas launch NaMuscla in Italy to treat myotonia in adults with NDM disorders
Lupin and Avas launch NaMuscla in Italy to treat myotonia in adults with NDM disorders: Our Bureau, Mumbai Tuesday, January 28, 2025, 16:45 Hrs [IST] Global pharma major Lupin Lim ...
Pharmabiz4h
Anavex Life Sciences’ Anavex 2-73 to treat neurodegenerative disorders receives US patent
Anavex Life Sciences’ Anavex 2-73 to treat neurodegenerative disorders receives US patent: New York Tuesday, January 28, 2025, 17:00 Hrs [IST] Anavex Life Sciences Corp., a clin ...
Pharmabiz7h
Pfizer’s BREAKWATER trial of Braftovi combo regimen demonstrates improved response in patients with BRAF V600E-mutant metastatic colorectal cancer
Pfizer’s BREAKWATER trial of Braftovi combo regimen demonstrates improved response in patients with BRAF V600E-mutant metastatic colorectal cancer: New York Tuesday, January 28, ...
Pharmabiz5h
Confluence of modern medicine and technology discussed at PIWOT-2025 in Mumbai
Confluence of modern medicine and technology discussed at PIWOT-2025 in Mumbai: Our Bureau, Mumbai Tuesday, January 28, 2025, 16:15 Hrs [IST] Leading experts from healthcare, medi ...
Pharmabiz5h
Stereotaxis’ MAGiC ablation catheter receives European CE Mark approval
Stereotaxis’ MAGiC ablation catheter receives European CE Mark approval: St. Louis Tuesday, January 28, 2025, 16:00 Hrs [IST] Stereotaxis, a pioneer and global leader in surgica ...
Pharmabiz6h
PureHealth buys majority stake in Hellenic Healthcare Group in USD 2.3 billion transaction
PureHealth buys majority stake in Hellenic Healthcare Group in USD 2.3 billion transaction: Abu Dhabi, UAE Tuesday, January 28, 2025, 15:00 Hrs [IST] PureHealth Holding PJSC, the ...
Pharmabiz11h
US FDA grants priority review status to Merck’s sNDA for Welireg to treat patients with advanced pheochromocytoma and paraganglioma
Rahway, New Jersey Tuesday, January 28, 2025, 10:00 Hrs [IST] ...
Pharmabiz12h
AHPI to host intl. conclave on 'Patient-Centred Care: Revolutionizing Hospital Management' in Kochi on Jan 31 & Feb 1
Revolutionizing Hospital Management' in Kochi on Jan 31 & Feb 1: Our Bureau, Bengaluru Tuesday, January 28, 2025, 09:00 Hrs [ ...
Pharmabiz10h
Dr Agarwal’s Health Care’s IPO to open on January 29, price band set at Rs. 382 to Rs. 402 per equity share
Dr Agarwal’s Health Care’s IPO to open on January 29, price band set at Rs. 382 to Rs. 402 per equity share: Our Bureau, Mumbai Tuesday, January 28, 2025, 10:45 Hrs [IST] Dr A ...